Prostate cancer: Improving PSA testing by adjusting for genetic background

Nature Reviews Urology

Volumn 10, Issue 4, 2013, Pages 190-192

  Scardino, Peter T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOLOGICAL MARKERS; GENETIC MARKERS; GENETIC TESTING; GENETIC VARIATION; HUMANS; MALE; MASS SCREENING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84876150925     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2013.28     Document Type: Short Survey

References (10)

1. Severi, G. et al. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA. Cancer Epidemiol. Biomarkers Prev. 15, 1142-1147 (2006).
2. Helfand, B. T. et al. Personalized PSA testing using genetic variants may reduce unnecessary prostate biopsies. J. Urol. doi:10.1016/j.juro.2012.12.023.
3. Liu, H., Wang, B. & Han, C. Meta-analysis of genome-wide and replication association studies on prostate cancer. Prostate 71, 209-224 (2011).
4. Eeles, R. A. et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 40, 316-321 (2008).
5. Loeb, S. et al. Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level. J. Urol. 182, 101-104 (2009).
6. Moyer, V. A. & U. S. Preventive Services Task Force. Screening for prostate cancer: U. S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 157, 120-134 (2012).
7. Gudmundsson, J. et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci. Transl. Med. 2, 62ra92 (2010).
8. Aly, M. et al. Polygenic risk score improves prostate cancer risk prediction: Results from the Stockholm 1 cohort study. Eur. Urol. 60, 21-28 (2011).
9. Loeb, S. et al. Prospective, multi-center evaluation of the Beckman Coulter Prostate Health Index using WHO calibration. J. Urol. doi:10.1016/j.juro.2012.11.149.
10. Vickers, A., Cronin, A. & Roobol, M. Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: An independent replication. J. Clin. Oncol. 28, 2493-2598 (2010).